The merger of two pioneers of psychedelic medicines has completed with the creation of AtaiBeckley, a company with a pipeline ...
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the ...
"The UK's inability to retain economic benefits of its R&D is a fatal flaw to any growth strategy," according to the document ...
The financial results show top-line sales growth in the first nine months of the year of 12% to DKK 230 billion ($35.4 ...
This article aims to share how to build an effective healthcare content strategy that boosts online patient engagement and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback